GWM
ABBV icon

Graybill Wealth Management’s AbbVie ABBV Stock Holding History

Graybill Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,705
Closed -$417K – 51
2019
Q4 		$417K Buy
4,705
+80
+2% +$6.64K 0.26% 41
2019
Q3 		$350K Buy
+4,625
New +$317K 0.24% 42
2013
Q3 		– Sell
-29,656
Closed -$1.23M – 60
2013
Q2 		$1.23M Buy
+29,656
New +$1.3M 1.1% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Graybill Wealth Management's ABBV Position: Q1 2020 in Review

Graybill Wealth Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 4,705 shares — an estimated $417K sold.

Graybill Wealth Management first reported a position in ABBV in Q2 2013 and held it in 3 quarters. The position peaked at $1.23M in Q2 2013. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Graybill Wealth Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • Graybill Wealth Management sold 4,705 AbbVie shares in Q1 2020, an estimated $417K.
  • Graybill Wealth Management first reported a position in AbbVie in Q2 2013 and held it in 3 quarters.
  • Graybill Wealth Management's AbbVie position peaked at $1.23M in Q2 2013.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Graybill Wealth Management's 13F filing for Q1 2020, filed 30 Apr 2020.